NCT00156546

Brief Summary

Our hypothesis is that long-term antimicrobial prophylaxis does not reduce the recurrence of infection and the risk of appearance of kidney scars in children with a documented previous upper UTI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
660

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started May 2000

Longer than P75 for phase_4

Geographic Reach
1 country

16 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2000

Completed
5.4 years until next milestone

First Submitted

Initial submission to the registry

September 7, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
Last Updated

December 1, 2005

Status Verified

September 1, 2005

First QC Date

September 7, 2005

Last Update Submit

November 30, 2005

Conditions

Keywords

Urinary tract infectionsChildrenAntibiotic prophylaxisRenal scintigraphyVesico ureteral reflux

Outcome Measures

Primary Outcomes (1)

  • The primary end-point is UTI Recurrence Rate during the 12-month observation period and the Development of renal damage (parenchymal scar) after 12 months.

Secondary Outcomes (1)

  • The secondary objectives are the comparison, in terms of efficacy and effectiveness, between two antimicrobial agents that are currently approved for prophylactic use: co-trimoxazole 15 mg/kg daily versus amoxicillin + clavulanic acid 15 mg/kg daily.

Interventions

Eligibility Criteria

Age2 Months - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 2 months and 6 years
  • Creatinine clearance (calculated according to Schwartz)  70 ml/min/1.73 m2 (for children in their first year of life, serum creatinine levels within normal range for age and sex)
  • First documented upper UTI (diagnostic criteria in Table 1)
  • Imaging Diagnostic work-up completed (Table 2) with at least the presence of an acute lesion at the DMSA scan and or a primary non severe reflux ( 1st or 3rd degree)
  • Informed consent of parents

You may not qualify if:

  • Patients with chronic renal insufficiency or  30% relative function of one kidney at DMSA scan
  • Patients with urinary tract disorders, such as vesico-ureteral reflux due to complex malformations of the urinary tract, obstruction of the posterior urethra, ureterocele or single kidney, neurogenic bladder
  • Patients with reflux  4th degree
  • Patients with pyelonephritis that developed during prophylaxis instituted because of prenatal diagnosis of urinary tract dilatation  Hypersensitivity to one of the two selected antimicrobial agents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Pediatric Unit, Ospedale di Belluno

Belluno, Belluno, Italy

Location

Pediatric Unit, Ospedale di Bentivoglio

Bentivoglio, Bologna, Italy

Location

- Pediatric Department, Ospedale di Bolzano

Bolzano, Bolzano, Italy

Location

Pediatric Unit, Ospedale di Cuneo

Cuneo, Cuneo, Italy

Location

Pediatric Unit, Ospedale di Este - Monselice

Monselice, Padova, Italy

Location

Nephrology, Dialysis and transplant Unit Pediatric Depatment,

Padua, Padova, 35128, Italy

Location

Pediatric Unit, Ospedale di Piove di Sacco e Chioggia

Piove di Sacco, Padova, Italy

Location

Pediatric Unit, Ospedale di Ravenna

Ravenna, Ravenna, Italy

Location

Pediatric Unit, Ospedale di Castelfranco

Castelfranco Veneto, Treviso, Italy

Location

Pediatric Unit, Ospedale di Motta di Livenza

Motta Di Livenza Oderzo, Treviso, Italy

Location

Pediatric Unit, Ospedale di Dolo

Dolo, Venezia, Italy

Location

Pediatric Unit, Ospedale di Soave

Soave, Verona, Italy

Location

Pediatric Unit, Ospedale di Schio/Thiene

Thiene, Vicenza, Italy

Location

Pediatric Department, Ospedale Maggiore

Bologna, Italy

Location

Pediatric Unit, Ospedale di Mestre

Mestre Venezia, Italy

Location

Pediatric Unit, Ospedale di Verona

Verona, Italy

Location

Related Publications (12)

  • Chon CH, Lai FC, Shortliffe LM. Pediatric urinary tract infections. Pediatr Clin North Am. 2001 Dec;48(6):1441-59. doi: 10.1016/s0031-3955(05)70385-0.

    PMID: 11732124BACKGROUND
  • Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1999 May;3(2):152-67. doi: 10.1034/j.1399-3046.1999.00011.x.

    PMID: 10389139BACKGROUND
  • Wennerstrom M, Hansson S, Jodal U, Stokland E. Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr. 2000 Jan;136(1):30-4. doi: 10.1016/s0022-3476(00)90045-3.

    PMID: 10636970BACKGROUND
  • Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearney DH, Reynolds EA, Ruley J, Janosky JE. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999 Jul;104(1 Pt 1):79-86. doi: 10.1542/peds.104.1.79.

    PMID: 10390264BACKGROUND
  • Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics. 1999 Apr;103(4):e54. doi: 10.1542/peds.103.4.e54.

    PMID: 10103346BACKGROUND
  • Hohenfellner K, Hunley TE, Brezinska R, Brodhag P, Shyr Y, Brenner W, Habermehl P, Kon V. ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Pediatr Nephrol. 1999 Aug;13(6):514-8. doi: 10.1007/s004670050649.

    PMID: 10452281BACKGROUND
  • Bollgren I. Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl. 1999 Nov;88(431):48-52. doi: 10.1111/j.1651-2227.1999.tb01318.x.

    PMID: 10588271BACKGROUND
  • Williams G, Lee A, Craig J. Antibiotics for the prevention of urinary tract infection in children: A systematic review of randomized controlled trials. J Pediatr. 2001 Jun;138(6):868-74. doi: 10.1067/mpd.2001.113785.

    PMID: 11391331BACKGROUND
  • Williams GJ, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2001;(4):CD001534. doi: 10.1002/14651858.CD001534.

    PMID: 11687116BACKGROUND
  • Ghiro L, Cracco AT, Sartor M, Comacchio S, Zacchello G, Dall'Amico R; Veneto Urinary Tract Infection Study Group. Retrospective study of children with acute pyelonephritis. Evaluation of bacterial etiology, antimicrobial susceptibility, drug management and imaging studies. Nephron. 2002 Jan;90(1):8-15. doi: 10.1159/000046308.

    PMID: 11744799BACKGROUND
  • Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, Cecchin D, Pavanello L, Molinari PP, Maschio F, Zanchetta S, Cassar W, Casadio L, Crivellaro C, Fortunati P, Corsini A, Calderan A, Comacchio S, Tommasi L, Hewitt IK, Da Dalt L, Zacchello G, Dall'Amico R; IRIS Group. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008 Nov;122(5):1064-71. doi: 10.1542/peds.2007-3770.

  • Hewitt IK, Zucchetta P, Rigon L, Maschio F, Molinari PP, Tomasi L, Toffolo A, Pavanello L, Crivellaro C, Bellato S, Montini G. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics. 2008 Sep;122(3):486-90. doi: 10.1542/peds.2007-2894.

MeSH Terms

Conditions

Urinary Tract InfectionsVesico-Ureteral Reflux

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrinary Bladder Diseases

Study Officials

  • Graziella Zacchello, Professor

    Departement of Pediatrics, University of Padova

    STUDY CHAIR
  • Antonella Toffolo, Dr

    Pediatric Unit Ospedale di Oderzo (TV) Italy

    PRINCIPAL INVESTIGATOR
  • Alessandro Calderan, Dr

    PRINCIPAL INVESTIGATOR
  • Giovanni Montini, Dr

    Nephrology, Dialysis and Transplant Unit, Pediatric Departement, Azienda Ospedaliera-Università, Padova

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 7, 2005

First Posted

September 12, 2005

Study Start

May 1, 2000

Study Completion

July 1, 2006

Last Updated

December 1, 2005

Record last verified: 2005-09

Locations